Timid research doesn't save lives. On Nov. 30, Fred Hutchinson Cancer Research Center brought several…
dcorriganDecember 7, 2021
A new biotech startup with operations in Seattle and Durham, N.C., has launched with $40…
dcorriganDecember 7, 2021
The UW Division of Nephrology is excited to welcome the 2022-23 incoming cohort of nephrology…
dcorriganDecember 6, 2021
The Fred Hutch/University of Washington Cancer Consortium has named Dr. Christopher Li its first associate director of…
dcorriganDecember 6, 2021
Research groups on opposite sides of the country are taking two very different approaches to…
dcorriganDecember 6, 2021
There’s not a lot known about the new COVID-19 variant Omicron, but what scientists see…
dcorriganDecember 3, 2021
Aberrant activation of the RAS family of guanosine triphosphatases (GTPases) is prevalent in lung adenocarcinoma,…
dcorriganDecember 3, 2021
On Dec. 1, Fred Hutchinson Cancer Research Center named computational biologist Dr. Robert Bradley scientific director of…
dcorriganDecember 3, 2021
Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve…
dcorriganDecember 2, 2021
